The Medical Reception Station (MRS) in Dhekelia supplies a prehospital emergency care (PHEC) service for the Eastern Sovereign Base Area and surrounding Cypriot cities. This service has been evaluated beforehand however some vital elements of care haven’t but been measured. The main goal of this examine was to undertake the most complete service analysis of the demand for the PHEC service at MRS Dhekelia over a 12-month interval. The secondary goal of this examine was to match findings in 2018 to these in 1995-1998 and 2013-2016.All calls to the PHEC crew between 01/07/2017 and 30/06/2018 have been reviewed and in contrast with beforehand reported information from 1995 to 1998 and 2013 to 2016.
Data have been collected from the prevalence e book, the logbook utilized by the PHEC crew to document the particulars of every name.There have been 164 calls to the PHEC service throughout the present examine interval. The quantity of activations has decreased since the 2013-2016 interval however stays better than 1995-1998. In each month there was a name to a scene the place a couple of casualty was current, with the highest quantity being 9 sufferers at one name. More calls have been obtained throughout the day (55%).
There have been extra calls as a result of of trauma than medical complaints (55% vs 45%). Trauma calls have decreased over 20 years. The frequency of neurological and psychiatric complaints has elevated over 20 years.The PHEC service at MRS Dhekelia is regularly used. The crew persistently face with scenes with a couple of casualty. Trauma is turning into much less frequent however psychiatric and neurological complaints are more and more frequent. These findings are vital for coaching and repair provision.
Most elements of our lives are ruled by massive, extremely developed establishments that combine a number of governance duties below one authority construction. But theorists differ as to the mechanisms that drive the improvement of such concentrated governance programs from rudimentary beginnings. Is the emergence of built-in governance schemes a symptom of consolidation of authority by small standing teams? Or does integration happen as a result of a posh establishment has extra potential responses to a posh surroundings?
Here we look at the emergence of advanced governance regimes in 5,000 sovereign, resource-constrained, self-governing on-line communities, ranging in scale from one to hundreds of customers. Each group begins with no group members and no governance infrastructure. As communities develop, they’re topic to choice pressures that maintain higher managed servers higher populated. We establish predictors of group success and take a look at the speculation that governance complexity can improve group health. We discover that what predicts success is determined by dimension: adjustments in complexity predict elevated success with bigger inhabitants servers. Specifically, governance guidelines in a big profitable group are extra quite a few and broader in scope.
Collaborating with Sovereign Tribal Nations to Legally Prepare for Public Health Emergencies.
Public well being emergencies, together with infectious illness outbreaks and pure disasters, are points confronted by each group. To handle these threats, it’s essential for all jurisdictions to grasp how legislation can be utilized to boost public well being preparedness, in addition to enhance coordination and collaboration throughout jurisdictions. As sovereign entities, Tribal governments have the authority to create their very own legal guidelines and take the vital steps to organize for, reply to, and get well from disasters and emergencies. Legal preparedness is a key part of public well being preparedness. This article first explains authorized preparedness and Tribal sovereignty after which describes the relationship between Tribal Nations, the US authorities, and states.
Specific Tribal considerations with respect to emergency preparedness and the significance of coordination and collaboration throughout jurisdictions for emergency preparedness are mentioned. Examples of collaborative efforts between Tribal and different governments to boost authorized preparedness are described. They additionally are inclined to rely extra on guidelines that focus energy in directors, and on guidelines that handle unhealthy habits and restricted server sources. Overall, this work is in step with theories that formal built-in governance programs emerge to arrange collective responses to interdependent useful resource administration issues, particularly as components reminiscent of inhabitants dimension exacerbate these issues.
‘Pulling the world in and pushing it away’: collaborating our bodies and the idea of coping.
In her lead article in this particular situation, Monica Greco (2018) gives the idea of collaborating our bodies as a ‘risk of conceiving our bodies themselves-and bodily occasions reminiscent of illness/illness-as expressing values and maybe even socially significant “preferences”‘. Such a place seeks to keep away from capitulation to a) a picture of bodily processes as with out values or responsiveness, object slightly than participant; b) a picture of human brokers as unitary, self-knowing, sovereign choosers-unless ailing. This article will discover this angle as utilized to the concept of coping.
The article will discover methods of on a regular basis residing, by way of specific consideration of Lauren Berlant’s studying of Two Girls, Fat and Thin by Mary Gaitskill. In her interpretation of the novel, Berlant assesses the sorts of issues for topics and our bodies that could be solved or managed by way of participation in or refraining from participation in considering, meals or intercourse.
![]() Alpha-bungarotoxin, CF680r |
|||
9-00003 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 100uG |
![]() Alpha-bungarotoxin, CF640r |
|||
9-00004 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 500uG |
![]() Alpha-bungarotoxin, CF640r |
|||
9-00004 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 100uG |
![]() Alpha-bungarotoxin, CF488a |
|||
9-00005 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 500uG |
![]() Alpha-bungarotoxin CF488a |
|||
9-00005 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 100uG |
![]() Alpha-bungarotoxin, CF568 |
|||
9-00006 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 500uG |
![]() Alpha-bungarotoxin, CF568 |
|||
9-00006 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 100uG |
![]() Alpha-bungarotoxin, CF594 |
|||
9-00007 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 500uG |
![]() Alpha-bungarotoxin CF594 |
|||
9-00007 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 100uG |
![]() Alpha-bungarotoxin, CF633 |
|||
9-00009 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 500uG |
![]() Alpha-bungarotoxin, CF633 |
|||
9-00009 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 100uG |
![]() Alpha-bungarotoxin |
|||
00010-1 | Biotium | 1MG | EUR 168 |
Description: Minimum order quantity: 1 unit of 1MG |
![]() Fluorescein-Alpha-bungarotoxin |
|||
00011 | Biotium | 500uG | EUR 367 |
Description: Minimum order quantity: 1 unit of 500uG |
![]() Tetramethylrhodamine-Alpha-bungarotoxin |
|||
00012 | Biotium | 500uG | EUR 383 |
Description: Minimum order quantity: 1 unit of 500uG |
![]() Fluorescein-alpha-bungarotoxin: (10x50ug) |
|||
00013 | Biotium | 10ST | EUR 417 |
Description: Minimum order quantity: 1 unit of 10ST |
![]() Tetramethylrhodamine-alpha-bungarotoxin: (10x50ug) |
|||
00014 | Biotium | 10ST | EUR 466 |
Description: Minimum order quantity: 1 unit of 10ST |
![]() Sulforhodamine 101-a-bungarotoxin (Texas Red--a-bungarotoxin): (500ug) |
|||
00015 | Biotium | 500uG | EUR 466 |
Description: Minimum order quantity: 1 unit of 500uG |
![]() Sulforhodamine 101-a-bungarotoxin (Texas Red--a-bungarotoxin): (10x50ug) |
|||
00016 | Biotium | 10ST | EUR 523 |
Description: Minimum order quantity: 1 unit of 10ST |
![]() Biotin-xx-a-bungarotoxin |
|||
00017 | Biotium | 500uG | EUR 433 |
Description: Minimum order quantity: 1 unit of 500uG |
![]() Alpha-Bungarotoxin, CF555 conjugate |
|||
9-00018 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 500uG |
![]() Alpha-Bungarotoxin, CF555 conjugate |
|||
9-00018 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 100ug |
![]() Biotin-cAMP, diisopropylethylammonium salt: |
|||
00020 | Biotium | 1MG | EUR 314 |
Description: Minimum order quantity: 1 unit of 1MG |
![]() Biotin-cAMP, diisopropylethylammonium salt: (20x50ug) |
|||
00020-1 | Biotium | 20ST | EUR 418 |
Description: Minimum order quantity: 1 unit of 20ST |
![]() Biotin-cGMP, diisopropylethylammonium salt: |
|||
00021 | Biotium | 1MG | EUR 344 |
Description: Minimum order quantity: 1 unit of 1MG |
![]() Biotin-cGMP, diisopropylethylammonium salt: (20x50ug) |
|||
00021-1 | Biotium | 20ST | EUR 448 |
Description: Minimum order quantity: 1 unit of 20ST |
![]() Cyanine 644-cAMP: |
|||
00022 | Biotium | 1MG | EUR 491 |
Description: Minimum order quantity: 1 unit of 1MG |
![]() Cyanine 644-cAMP: (20x50ug) |
|||
00022-1 | Biotium | 20ST | EUR 625 |
Description: Minimum order quantity: 1 unit of 20ST |
![]() Fluorescein Methotrexate, triammonium salt: |
|||
00023 | Biotium | 1MG | EUR 281 |
Description: Minimum order quantity: 1 unit of 1MG |
![]() Staurosporine |
|||
00025 | Biotium | 100uG | EUR 139 |
Description: Minimum order quantity: 1 unit of 100uG |
![]() Alpha-bungarotoxin, CF543 |
|||
00026 | Biotium | 500uG | EUR 494 |
Description: Minimum order quantity: 1 unit of 500uG |
![]() Rhodamine phalloidin 300u |
|||
00027 | Biotium | 300 | EUR 345 |
Description: Minimum order quantity: 1 unit of 300 |
![]() Biotin-xx-phalloidin |
|||
00028 | Biotium | 100U | EUR 428 |
Description: Minimum order quantity: 1 unit of 100U |
![]() Fluorescein-phalloidin |
|||
00030 | Biotium | 300U | EUR 345 |
Description: Minimum order quantity: 1 unit of 300U |
![]() Rhodamine 110 phalloidin |
|||
00032 | Biotium | 300ST | EUR 345 |
Description: Minimum order quantity: 1 unit of 300ST |
![]() Sulforhodamine 101 (Texas-Red) Phalloidin |
|||
00033 | Biotium | 300EU | EUR 345 |
Description: Minimum order quantity: 1 unit of 300EU |
![]() Phalloidin, CF405M |
|||
00034 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
![]() Phalloidin, CF405M |
|||
00034-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
![]() CF488A-cAMP |
|||
00036 | Biotium | 100ug | EUR 172 |
Description: Minimum order quantity: 1 unit of 100ug |
![]() CF640R-cAMP |
|||
00037 | Biotium | 100ug | EUR 172 |
Description: Minimum order quantity: 1 unit of 100ug |
![]() Phalloidin, CF555 |
|||
00040 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
![]() Phalloidin, CF555 |
|||
00040-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
![]() Phalloidin, CF647 |
|||
00041 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
![]() Phalloidin, CF647 |
|||
00041-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
![]() Phalloidin, CF488A |
|||
00042 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
![]() Phalloidin, CF488A |
|||
00042-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
![]() Phalloidin, CF543 |
|||
00043 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
![]() Phalloidin, CF543 |
|||
00043-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
![]() Phalloidin, CF568 |
|||
00044 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
![]() Phalloidin, CF568 |
|||
00044-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
![]() Phalloidin, CF594 |
|||
00045 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
![]() Phalloidin, CF594 |
|||
00045-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
![]() Phalloidin, CF633 |
|||
00046 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
![]() Phalloidin, CF633 |
|||
00046-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
![]() Phalloidin, CF660R |
|||
00047 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
![]() Phalloidin, CF660R |
|||
00047-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
![]() Phalloidin, CF680R |
|||
00048 | Biotium | 300U | EUR 466 |
Description: Minimum order quantity: 1 unit of 300U |
![]() Phalloidin, CF680R |
|||
00048-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
![]() Phalloidin, CF350 |
|||
00049 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
![]() Phalloidin, CF350 |
|||
00049-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
![]() Phalloidin, CF640R |
|||
00050 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
![]() Phalloidin, CF640R |
|||
00050-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
![]() Phalloidin, CF532 |
|||
00051 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
![]() Phalloidin, CF532 |
|||
00051-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
![]() Phalloidin, CF660C |
|||
00052 | Biotium | 300U | EUR 442 |
Description: Minimum order quantity: 1 unit of 300U |
![]() Phalloidin, CF660C |
|||
00052-T | Biotium | 50U | EUR 133 |
Description: Minimum order quantity: 1 unit of 50U |
![]() Phalloidin, CF680 |
|||
00053 | Biotium | 300U | EUR 466 |
Description: Minimum order quantity: 1 unit of 300U |
![]() Phalloidin, CF680 |
|||
00053-T | Biotium | 50U | EUR 147 |
Description: Minimum order quantity: 1 unit of 50U |
![]() Phalloidin, CF430 |
|||
00054 | Biotium | 300U | EUR 449 |
Description: Minimum order quantity: 1 unit of 300U |
![]() Phalloidin, CF430 |
|||
00054-T | Biotium | 50U | EUR 139 |
Description: Minimum order quantity: 1 unit of 50U |
![]() Phalloidin, CF440 |
|||
00055 | Biotium | 300U | EUR 449 |
Description: Minimum order quantity: 1 unit of 300U |
![]() Phalloidin, CF440 |
|||
00055-T | Biotium | 50U | EUR 139 |
Description: Minimum order quantity: 1 unit of 50U |
![]() Cholera Toxin Subunit B, CF488A conjugate |
|||
00070 | Biotium | 100ug | EUR 261 |
Description: Minimum order quantity: 1 unit of 100ug |
![]() Cholera Toxin Subunit B, CF568 conjugate |
|||
00071 | Biotium | 100ug | EUR 261 |
Description: Minimum order quantity: 1 unit of 100ug |
![]() Cholera Toxin Subunit B, CF594 conjugate |
|||
00072 | Biotium | 100ug | EUR 261 |
Description: Minimum order quantity: 1 unit of 100ug |
![]() Cholera Toxin Subunit B, CF640R conjugate |
|||
00073 | Biotium | 100ug | EUR 264 |
Description: Minimum order quantity: 1 unit of 100ug |
![]() Cholera Toxin Subunit B, CF532 conjugate |
|||
00074 | Biotium | 100ug | EUR 264 |
Description: Minimum order quantity: 1 unit of 100ug |
![]() Cholera Toxin Subunit B, CF543 conjugate |
|||
00075 | Biotium | 100ug | EUR 264 |
Description: Minimum order quantity: 1 unit of 100ug |
![]() Cholera Toxin Subunit B, CF620R conjugate |
|||
00076 | Biotium | 100ug | EUR 264 |
Description: Minimum order quantity: 1 unit of 100ug |
![]() Cholera Toxin Subunit B, CF633 conjugate |
|||
00077 | Biotium | 100ug | EUR 264 |
Description: Minimum order quantity: 1 unit of 100ug |
![]() Cholera Toxin Subunit B, CF660R conjugate |
|||
00078 | Biotium | 100ug | EUR 264 |
Description: Minimum order quantity: 1 unit of 100ug |
![]() Cholera Toxin Subunit B, CF680R conjugate |
|||
00079 | Biotium | 100ug | EUR 282 |
Description: Minimum order quantity: 1 unit of 100ug |
![]() Human Transferrin, CF488A conjugate |
|||
00081 | Biotium | 1mg | EUR 149 |
Description: Minimum order quantity: 1 unit of 1mg |
![]() Human Transferrin, CF543 conjugate |
|||
00082 | Biotium | 1mg | EUR 149 |
Description: Minimum order quantity: 1 unit of 1mg |
![]() Human Transferrin, CF568 conjugate |
|||
00083 | Biotium | 1mg | EUR 149 |
Description: Minimum order quantity: 1 unit of 1mg |
![]() Human Transferrin, CF594 conjugate |
|||
00084 | Biotium | 1mg | EUR 149 |
Description: Minimum order quantity: 1 unit of 1mg |
![]() Human Transferrin, CF640R conjugate |
|||
00085 | Biotium | 1mg | EUR 149 |
Description: Minimum order quantity: 1 unit of 1mg |
![]() Human Transferrin, CF680R conjugate |
|||
00086 | Biotium | 1mg | EUR 149 |
Description: Minimum order quantity: 1 unit of 1mg |
![]() Human Transferrin, CF750 conjugate |
|||
00087 | Biotium | 1mg | EUR 155 |
Description: Minimum order quantity: 1 unit of 1mg |
![]() HIV-1 tat recombinant antigen |
|||
00110-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HIV-1 tat recombinant antigen full length 15 kDa |
![]() HIV-1 tat recombinant antigen |
|||
00110-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HIV-1 tat recombinant antigen full length 15 kDa |
![]() HIV-1 GAG P24 Recombinant Antigen |
|||
00111-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
![]() HIV-1 GAG P24 Recombinant Antigen |
|||
00111-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
![]() HIV-1 nef recombinant antigen |
|||
00112-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HIV-1 nef recombinant antigen a.a 3 to a.a 190 of the HIV-1 nef region 20 kDa |
![]() HIV-1 nef recombinant antigen |
|||
00112-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HIV-1 nef recombinant antigen a.a 3 to a.a 190 of the HIV-1 nef region 20 kDa |
![]() HIV-1 env gp41 recombinant antigen |
|||
00113-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HIV-1 env gp41 recombinant antigen a.a 466 to a.a 753 of the HIV-1 env region 32 kDa |
![]() HIV-1 env gp41 recombinant antigen |
|||
00113-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HIV-1 env gp41 recombinant antigen a.a 466 to a.a 753 of the HIV-1 env region 32 kDa |
![]() HIV-2 GP 36 Recombinant Antigen |
|||
00114-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HIV -2 env gp36 recombinant antigen a.a 390 to a.a 702 of the HIV-2 env region 34 kDa |
![]() HIV-2 GP 36 Recombinant Antigen |
|||
00114-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HIV -2 env gp36 recombinant antigen a.a 390 to a.a 702 of the HIV-2 env region 34 kDa |
![]() HCV core recombinant antigen |
|||
00115-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa |
![]() HCV core recombinant antigen |
|||
00115-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa |
![]() HCV core recombinant antigen, Biotin conjugate |
|||
00115-V-B-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Biotin conjugate. |
![]() HCV core recombinant antigen, Biotin conjugate |
|||
00115-V-B-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Biotin conjugate. |
![]() HCV core recombinant antigen, FITC conjugate |
|||
00115-V-F-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Fluorescein conjugate. |
![]() HCV core recombinant antigen, FITC conjugate |
|||
00115-V-F-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Fluorescein conjugate. |
![]() HCV core recombinant antigen, Rhodamine |
|||
00115-V-R-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa . Rhodamine conjugate. |
![]() HCV core recombinant antigen, Rhodamine |
|||
00115-V-R-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa . Rhodamine conjugate. |
![]() HCV NS4 recombinant antigen NS4a+b |
|||
00116-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. |
![]() HCV NS4 recombinant antigen NS4a+b |
|||
00116-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. |
![]() HCV NS4 recombinant antigen NS4a+b, Biotin |
|||
00116-V-B-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Biotin conjugate. |
![]() HCV NS4 recombinant antigen NS4a+b, Biotin |
|||
00116-V-B-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Biotin conjugate. |
![]() HCV NS4 recombinant antigen NS4a+b, FITC |
|||
00116-V-F-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Fluorescein conjugate. |
![]() HCV NS4 recombinant antigen NS4a+b, FITC |
|||
00116-V-F-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Fluorescein conjugate. |
![]() HCV NS4 recombinant antigen NS4a+b, Rhodamine |
|||
00116-V-R-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Rhodamine conjugate. |
![]() HCV NS4 recombinant antigen NS4a+b, Rhodamine |
|||
00116-V-R-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Rhodamine conjugate. |
![]() HCV NS3 recombinant antigen |
|||
00117-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HCV NS3 recombinant antigen a.a 1400 to a.a 1643 of HCV polyprotein 22 kDa |
![]() HCV NS3 recombinant antigen |
|||
00117-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HCV NS3 recombinant antigen a.a 1400 to a.a 1643 of HCV polyprotein 22 kDa |
![]() HBV core recombinant antigen |
|||
00120-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HBV core recombinant antigen HBcAg a.a 1 to a.a 183 of HBV core antigen 18 kDa |
![]() HBV core recombinant antigen |
|||
00120-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HBV core recombinant antigen HBcAg a.a 1 to a.a 183 of HBV core antigen 18 kDa |
![]() HBV core recombinant antigen, Delta |
|||
00121-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HBV core recombinant antigen HBcAg a.a 1 to a.a 144 of HBV core antigen 16 kDa |
![]() HBV core recombinant antigen, Delta |
|||
00121-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HBV core recombinant antigen HBcAg a.a 1 to a.a 144 of HBV core antigen 16 kDa |
![]() HBV surface recombinant antigen HBsAg |
|||
00122-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant |
![]() HBV surface recombinant antigen HBsAg |
|||
00122-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant |
![]() HBV surface recombinant antigen HBsAg antigen |
|||
00123-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant High purity |
![]() HBV surface recombinant antigen HBsAg antigen |
|||
00123-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant High purity |
![]() HBV surface recombinant antigen HBsAg antigen |
|||
00124-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HBV surface recombinant antigen HBsAg antigen 31 kDa E. coli recombinant |
![]() HBV surface recombinant antigen HBsAg antigen |
|||
00124-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HBV surface recombinant antigen HBsAg antigen 31 kDa E. coli recombinant |
![]() HEV (Birma) ORF2 recombinant antigen |
|||
00131-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HEV (Birma) ORF2 recombinant antigen a.a. 633 to a.a 659. |
![]() HEV (Birma) ORF2 recombinant antigen |
|||
00131-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HEV (Birma) ORF2 recombinant antigen a.a. 633 to a.a 659. |
![]() HEV (Birma) ORF2 recombinant antigen |
|||
00132-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HEV (Birma) ORF2 recombinant antigen a.a. 403 to a.a 461. |
![]() HEV (Birma) ORF2 recombinant antigen |
|||
00132-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HEV (Birma) ORF2 recombinant antigen a.a. 403 to a.a 461. |
![]() AA 403-461 HEV Birma ORF2 Recombinant Antigen |
|||
00133-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: HEV (Birma) ORF2 recombinant antigen a.a. 92 to a.a 123. |
![]() AA 403-461 HEV Birma ORF2 Recombinant Antigen |
|||
00133-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: HEV (Birma) ORF2 recombinant antigen a.a. 92 to a.a 123. |
![]() T, Pallidum recombinant antigen p15 |
|||
00141-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: T. Pallidum recombinant antigen p15 (full length) |
![]() T, Pallidum recombinant antigen p15 |
|||
00141-V-1000ug | Virogen | 1000 ug | EUR 1282.5 |
Description: T. Pallidum recombinant antigen p15 (full length) |
![]() T, Pallidum recombinant antigen p17 |
|||
00142-V-01mg | Virogen | 0,1 mg | EUR 267.5 |
Description: T. Pallidum recombinant antigen p17 (full length) |
The account of coping and embodiment in Berlant’s reflections will then be positioned in dialogue with findings by Alexandra Michel, who watched the course of of bodily burnout in funding banking associates throughout a 13-year cultural ethnography, observing as the bankers heeded or ignored the cues their our bodies gave about the limits of possible calls for. The article as a complete gives an illustration of the worth of Greco’s reflections for providing a contemporary and beneficial perspective on the idea of coping.